aids
Turing Pharma names chairman to replace Shkreli as CEO
December 20, 2015 by publisher · Leave a Comment
(Reuters) – Martin Shkreli, the poster boy for prescription drug price increases who was arrested for securities fraud this week, has stepped down from his post as chief executive officer of Turing Pharmaceuticals Inc, the company said on Friday. Shkreli was replaced by Turing Chairman Ron Tilles, who said in a statement that the company was committed to continuing…
View original post here:
Turing Pharma names chairman to replace Shkreli as CEO
aids
Fed’s Lacker says four rate hikes in 2016 would be ‘gradual’
December 20, 2015 by creative · Leave a Comment
Federal Reserve forecasts pointing to four interest rate hikes in 2016 show what the U.S. central bank means when it says it anticipates raising rates at a “gradual pace,” Richmond Fed President Jeffrey Lacker said on Friday.
See the original post:
Fed’s Lacker says four rate hikes in 2016 would be ‘gradual’
aids
Martin Shkreli says securities fraud charges are ‘baseless’
December 20, 2015 by publisher · Leave a Comment
By Frank McGurty NEW YORK (Reuters) – Martin Shkreli, the pharmaceuticals entrepreneur vilified for jacking up the price of a life-saving AIDS drug, said on Saturday that unrelated securities fraud allegations that resulted in his arrest this week were “baseless and …
See the original post:
Martin Shkreli says securities fraud charges are ‘baseless’
aids
Martin Shkreli says securities fraud charges are ‘baseless’
December 20, 2015 by admin · Leave a Comment
By Frank McGurty NEW YORK (Reuters) – Martin Shkreli, the pharmaceuticals entrepreneur vilified for jacking up the price of a life-saving AIDS drug, said on Saturday that unrelated securities fraud allegations that resulted in his arrest this week were “baseless and without merit.” Federal prosecutors have alleged that Shkreli was running a Ponzi-like scheme at his former hedge fund and a company he headed …
Read the original here:
Martin Shkreli says securities fraud charges are ‘baseless’